Roche's New Breast Cancer Trial Pits Its Pipeline Against Eli Lilly's Standard: What It Means for RHHBY

TipRanks00:32

Eli Lilly and Co is preparing for the oral weight-loss drug market by building up sufficient inventory in anticipation of FDA approval.

Pharmaceutical giant Eli Lilly and Co has built up inventory for its experimental weight-loss oral drug orforglipron, as it awaits a potential approval decision by the U.S. Food and Drug Administration (FDA) on this oral GLP-1 medication in the coming months.

Zhitong FinanceFeb 13 23:16

Immunic Rises After $400M Private Placement, Leadership Transition

Seeking AlphaFeb 13 21:46

Fitch Maintains Ratings of Hikma, Roche Following Corporate Rating Criteria Updates

MT NewswiresFeb 13 16:57

Express News | Novo-Nordisk A/S will follow Eli Lilly and Co's lead by launching a bottled weight-loss injection.

BreakingsFeb 12 06:32

Labcorp Launches US FDA-Cleared Alzheimer's Blood Test for Primary Care Use

MT NewswiresFeb 11 21:36